Optimizing the use of Paxlovid in clinical practice.
Sign Up to like & getrecommendations! Published in 2022 at "Drugs of today"
DOI: 10.1358/dot.2022.58.11.3461265
Abstract: On December 22, 2021, the United States Food and Drug Administration (FDA) issued an emergency use authorization (EUA) for nirmatrelvir/ritonavir (Paxlovid) for the treatment of mild to moderate coronavirus disease 2019 (COVID-19). The drug is… read more here.
Keywords: use paxlovid; clinical practice; paxlovid clinical; optimizing use ... See more keywords